The India-UK Free Trade Agreement (FTA), scheduled to take effect on July 15, is expected to strengthen India’s pharmaceutical and medical technology sectors by increasing exports, attracting investment, and deepening collaboration in research, manufacturing, and innovation, according to industry leaders. They, however, said the agreement’s full benefits would depend on greater regulatory harmonisation, mutual recognition of quality standards, and faster product approval pathways.
The India-UK Free Trade Agreement (FTA), scheduled to take effect on July 15, is expected to strengthen India’s pharmaceutical and medical technology sectors by increasing exports, attracting investment, and deepening collaboration in research, manufacturing, and innovation, according to industry leaders. They, however, said the agreement’s full benefits would depend on greater regulatory harmonisation, mutual recognition of quality standards, and faster product approval pathways.